AU4399985A - Oxadiazoles - Google Patents

Oxadiazoles

Info

Publication number
AU4399985A
AU4399985A AU43999/85A AU4399985A AU4399985A AU 4399985 A AU4399985 A AU 4399985A AU 43999/85 A AU43999/85 A AU 43999/85A AU 4399985 A AU4399985 A AU 4399985A AU 4399985 A AU4399985 A AU 4399985A
Authority
AU
Australia
Prior art keywords
oxadiazoles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43999/85A
Inventor
Erich Cohnen
Petra Jacobitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beiersdorf AG
Original Assignee
Beiersdorf AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf AG filed Critical Beiersdorf AG
Publication of AU4399985A publication Critical patent/AU4399985A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AU43999/85A 1984-06-26 1985-06-24 Oxadiazoles Abandoned AU4399985A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843423429 DE3423429A1 (en) 1984-06-26 1984-06-26 SUBSTITUTED PHENOXYALKYLAMINOPROPANOLE, METHOD FOR THE PRODUCTION AND USE THEREOF, AND PREPARATIONS CONTAINING THESE COMPOUNDS
DE3423429 1984-06-26

Publications (1)

Publication Number Publication Date
AU4399985A true AU4399985A (en) 1986-01-02

Family

ID=6239117

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43999/85A Abandoned AU4399985A (en) 1984-06-26 1985-06-24 Oxadiazoles

Country Status (5)

Country Link
EP (1) EP0166331A3 (en)
JP (1) JPS6124579A (en)
AU (1) AU4399985A (en)
DE (1) DE3423429A1 (en)
ES (1) ES8608498A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993009106A1 (en) * 1991-10-28 1993-05-13 Tsentr Po Khimii Lekarstvennykh Sredstv Derivatives of 5-phenoxymethyl-1,2,4-oxadiazol, their salts, method of obtaining them and a pharmaceutical preparation with antihypertensive, antianginal, antiarrhythmic and antiglaucomatomic properties based on them
IL152528A0 (en) * 2000-07-13 2003-05-29 Lilly Co Eli Beta3 adrenergic agonists
US6825220B2 (en) 2000-11-10 2004-11-30 Eli Lilly And Company 3-Substituted oxindole β 3 agonists
DE60211199T2 (en) 2001-08-14 2007-02-01 Eli Lilly And Co., Indianapolis 3-SUBSTITUTED OXINDOL BETA-3 AGONISTS
WO2003016307A1 (en) * 2001-08-14 2003-02-27 Eli Lilly And Company β3 ADRENERGIC AGONISTS
JP2005518357A (en) 2001-11-20 2005-06-23 イーライ・リリー・アンド・カンパニー Beta 3 adrenergic agonist
JP2005514366A (en) 2001-11-20 2005-05-19 イーライ・リリー・アンド・カンパニー 3-Substituted oxindole β3 agonist
EP1467733A1 (en) 2002-01-11 2004-10-20 Eli Lilly And Company 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5231858B1 (en) * 1969-12-17 1977-08-17
DE2811638A1 (en) * 1978-03-17 1979-09-20 Beiersdorf Ag 1-Aryloxy-3-amino-2-propanol derivs. - with beta-adrenolytic and hypotensive activity, used to treat angina pectoris, hypertension and arrhythmia
WO1980000152A1 (en) * 1978-07-03 1980-02-07 Sandoz Ag 3-aminopropoxy-aryl derivates,preparation and use thereof
DE2926517A1 (en) * 1979-06-30 1981-01-15 Beiersdorf Ag SUBSTITUTED 3-ARYL-PYRAZOLE AND 5-ARYL-ISOXAZOLE AND METHOD FOR THE PRODUCTION THEREOF
DE3005287A1 (en) * 1980-02-13 1981-08-20 Basf Ag, 6700 Ludwigshafen PHENYLPIPERAZINE DERIVATIVES OF 1,3,4-OXADIAZOLYLPHENOLS, THEIR PRODUCTION AND THERAPEUTIC AGENTS CONTAINING THEM
DE3006351A1 (en) * 1980-02-20 1981-09-17 Basf Ag, 6700 Ludwigshafen 2-((3-Amino-2-hydroxy-propoxy)styryl) derivs. - are beta:sympatholytics more effective than propranol for treatment of hypertonia, angina pectoris and cardiac arrhythmia
DE3006809A1 (en) * 1980-02-23 1981-09-24 Basf Ag, 6700 Ludwigshafen 2 - ((3-AMINO-2-HYDROXY-PROPOXY) -STYRYL) -ISOXAZOLES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
DE3030530A1 (en) * 1980-08-13 1982-03-18 Beiersdorf Ag, 2000 Hamburg ALKYL- AND CYCLOALKYL-SUBSTITUTED 2- (2 - (- HYDROXY-3-TERT-BUTYLAMINO-PROPOXY) -5-ACYLAMINOPHENYL) -1,3,4-OXADIAZOLES, METHOD FOR THE PRODUCTION THEREOF AND THESE COMPOUNDS
DE3030573A1 (en) * 1980-08-13 1982-03-11 Beiersdorf Ag, 2000 Hamburg Hydroxy-3-tert. butylamino-propoxy-acetamido-phenyl oxadiazole - beta-adrenolytic suitable for treating angina pectoris, hypertonia and arrhythmia
DE3030561A1 (en) * 1980-08-13 1982-03-25 Beiersdorf Ag, 2000 Hamburg Cardio:selective beta-blocker, 1-amino-3-phenoxy-2-propanol derivs. - which are 2- 2'-hydroxy-tert.-butylamino-propoxy-5'-acylamino-phenyl- 1,3,4-oxadiazole cpds.
DE3200304A1 (en) * 1981-01-16 1982-08-26 Sandoz-Patent-GmbH, 7850 Lörrach 3-AMINOPROPOXYARYL DERIVATIVES, THEIR PRODUCTION AND MEDICINAL PRODUCTS CONTAINING THEM

Also Published As

Publication number Publication date
EP0166331A2 (en) 1986-01-02
DE3423429A1 (en) 1986-01-02
EP0166331A3 (en) 1986-11-12
JPS6124579A (en) 1986-02-03
ES8608498A1 (en) 1986-07-16
ES544511A0 (en) 1986-07-16

Similar Documents

Publication Publication Date Title
AU4568985A (en) Tryptamine-5-methanesulfonamide
AU4401185A (en) Belastungsabhangig frequenzvariabler herzschrittmacher
AU4222285A (en) Pyrrolobenzimidazoles
AU3839785A (en) Sammelpackung
AU4254685A (en) Arylhydroxamates
AU4256585A (en) 1-heteroaryl-4-aryl-pyrazolin-5-ones
AU3749685A (en) Induktionsmotor
AU4105285A (en) Tetrahydrofuran-2-ylmethylamines
AU4061285A (en) Schaltersicherungseinheit
AU4118385A (en) Verbindungselement
AU4299085A (en) Medizinisches schwingbett
AU4422985A (en) Leucotriene-antagonistic thioethehers
AU4542985A (en) Linear-antriebsvorrichtung
AU4459585A (en) Morpholinols
AU4541685A (en) Bandspanne
AU4544085A (en) Fiberdoseringsanordning
AU4399985A (en) Oxadiazoles
AU4357485A (en) Injektionsspritze
AU4271085A (en) Metallophosphoaluminates
AU4274285A (en) Cycloalkane-indene-carboximidamides
AU4216685A (en) Aminocarnitines
AU4061585A (en) Automatisk fadolsaftapningsanlaeg
AU4489185A (en) Pyridazinylimidazolinones
AU4501885A (en) Gudgeon-pin
AU4356785A (en) Reinigungsburste